Navigation Links
Drug-Eluting Stents Safe After Heart Attack
Date:3/30/2008

Long-term study indicates they lower restenosis risk and don't increase mortality probability

SUNDAY, March 30 (HealthDay News) -- Drug-eluting stents, the small tubing placed in diseased coronary arteries to keep them open, are more effective than bare-metal stents for heart attack patients, new research shows.

In the largest study yet comparing the long-term effect of drug-eluting stents -- the drug in question retards the growth of arterial cells -- with drug-free ones, Boston researchers report the drug-eluting device lowers the risk of blood vessels narrowing again and doesn't heighten the risk of mortality.

In analyzing data from 7,216 Massachusetts patients who had stents implanted after having suffered a heart attack known as a myocardial infarction (MI), the researchers concluded that those patients who had drug-eluting stents had a 5 percent better chance of the diseased artery remaining open.

Additionally, they found, those who had an MI and got drug-eluting stents were 1.5 percent less likely than patients with bare-metal stents to have another heart attack in the two-year period that was studied. Mortality was 2.8 percent less likely in patients with drug-eluting stents, the researchers said.

The findings follow earlier smaller studies this year that showed the drug-eluting stents may be safe for MI patients but questioned their long-term effectiveness.

The new research was to be presented Sunday at a joint meeting of the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology in Chicago.

"This study confirms that the same benefits that drug-eluting stents offer other patients in preventing restenosis [re-narrowing] of the coronary arteries are still there for patients with MI, and there doesn't appear to be any trade-off in increased risk of repeat MI or death," Dr. Laura Mauri, the study's lead researcher, said in a prepared statement.

"I would feel comfortable considering drug-eluting stents on the basis of these results -- with the caveats that treated patients must be able to take antiplatelet therapy and that we definitely want to see even longer-term follow-up," added Mauri, who is chief scientific officer at the Harvard Clinical Research Institute, as well as a Brigham and Womens Hospital cardiologist and an assistant professor of medicine at Harvard Medical School.

More information

The U.S. government has more information on how stenting works.



-- Barry Hoffman



SOURCE: American College of Cardiology and Society for Cardiovascular Angiography and Interventions, news release, March 30, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
2. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
3. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
4. New Drug Shows Promise in Use With Coronary Stents
5. Experts Offer Clarity on Confusion Surrounding Stents
6. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
7. Study Finds Both Coated Stents Perform the Same
8. Stents Slightly Better Than Bypass for Blocked Left Coronary Artery
9. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
10. Surgery Better Than Stents for Multiple Blockages
11. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug-Eluting Stents Safe After Heart Attack
(Date:3/24/2017)... ... March 24, 2017 , ... ... (ONS) wanted to create a communications platform that positions them as the go-to ... and ONS reinvented their online publication as an always-on, always-fresh news, views and ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... ... ... The MBI “Hall of Fame” recognizes the contributions of those whose careers are or were ... careers of all others involved. , On Monday, March 21st, 2017 Laurie Robert, ... Fame. The induction took place during the World of Modular – Award Gala in ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for the ... Europe , Asia-Pacific , Latin ... provided for the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:3/24/2017)... -- HealthMine surveys with 9,250 insured consumers fielded from February ... want help from their plans in five key areas: ... 2) help closing gaps in care, 3) better digital ... relevant, real-time guidance. Meeting these needs is essential to ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... and GENEVA , March 24, ... World Tuberculosis Day revitalizes efforts to develop sutezolid as ... On World Tuberculosis Day, TB Alliance and the Medicines ... clinical development of sutezolid, an antibiotic drug candidate which ... to the development of sutezolid in combination with other ...
Breaking Medicine Technology: